Abstract
Background: Magnetic resonance spectroscopy (MRS) has been used to identify gamma-aminobutyric acid (GABA) alterations in mood disorders, particularly in the medial prefrontal cortex (mPFC) where decreased concentrations have been associated with anhedonia. In major depressive disorder (MDD), prior work suggests that repetitive transcranial magnetic stimulation (rTMS) increases mPFC GABA concentrations proportional to antidepressant response. To our knowledge, this has not been examined in acute bipolar depression.Methods: As part of a multicentre 4-week randomized, double-blind, sham-controlled trial using intermittent theta-burst stimulation (iTBS) of the left dorsolateral prefrontal cortex (DLPFC) in individuals with acute bipolar depression, we quantified mPFC GABA and Glx (glutamate+glutamine) concentrations using a 3T MRS scan at baseline and after the intervention. Depressive symptoms were measured using the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale-17 (HRDS-17), and anhedonia was measured using the Snaith-Hamilton Pleasure Scale (SHAPS).Results: The trial was terminated for futility and magnetic resonance spectroscopy data was acquired for 18 participants. At baseline, there were no associations between GABA or Glx concentrations and anhedonia, however GABA was negative correlated with depressive symptom severity on the HRDS-17. Compared to the sham-iTBS group, participants receiving active-iTBS had a significant increase in mPFC GABA concentrations. This was unrelated to antidepressant outcomes or improvements in anhedonia.Conclusion: Our data suggests that iTBS targeting the DLPFC is associated with physiological changes in the mPFC. In acute bipolar depression, our preliminary data suggests that mPFC GABA is dissociated from antidepressant iTBS treatment outcomes and anhedonia.
Highlights
Bipolar disorder (BD) is a leading cause of global disability that is defined by episodes of mania or hypomania [1]
Twenty-one participants were randomized between sham-intermittent theta-burst stimulation (iTBS) (n = 10) and active iTBS-repetitive transcranial magnetic stimulation (rTMS) groups (n = 11)
MPFC gamma-aminobutyric acid (GABA) concentrations at baseline were skewed with one notable outlier >3 standard deviations from the mean
Summary
Bipolar disorder (BD) is a leading cause of global disability that is defined by episodes of mania or hypomania [1]. Non-invasive neurostimulation techniques, such as transcranial magnetic stimulation (TMS), are efficacious in the treatment of Major Depressive Disorder (MDD). They are often considered in acute bipolar depression, the literature in BD is small [4, 5]. In major depressive disorder (MDD), prior work suggests that repetitive transcranial magnetic stimulation (rTMS) increases mPFC GABA concentrations proportional to antidepressant response. To our knowledge, this has not been examined in acute bipolar depression
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have